165 related articles for article (PubMed ID: 36760714)
1. High prevalence of Wilms tumor 1 expression in multiple myeloma and plasmacytoma: A cohort of 142 Asian patients' samples.
Phikulsod P; Sukpanichnant S; Kunacheewa C; Chieochansin T; Junking M; Yenchitsomanus PT
Pathol Oncol Res; 2023; 29():1610844. PubMed ID: 36760714
[TBL] [Abstract][Full Text] [Related]
2. WT1 expression level and clinical factors in multiple myeloma.
Hatta Y; Takeuchi J; Saitoh T; Itoh T; Ishizuka H; Iriyama N; Miyajima T; Kaneita Y; Saiki M; Yasukawa K; Yasukawa R; Kura Y; Nishinarita S; Sawada U; Horie T
J Exp Clin Cancer Res; 2005 Dec; 24(4):595-9. PubMed ID: 16471322
[TBL] [Abstract][Full Text] [Related]
3. Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.
Tsuboi A; Oka Y; Nakajima H; Fukuda Y; Elisseeva OA; Yoshihara S; Hosen N; Ogata A; Kito K; Fujiki F; Nishida S; Shirakata T; Ohno S; Yasukawa M; Oji Y; Kawakami M; Morita S; Sakamoto J; Udaka K; Kawase I; Sugiyama H
Int J Hematol; 2007 Dec; 86(5):414-7. PubMed ID: 18192109
[TBL] [Abstract][Full Text] [Related]
4. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoma in patients with multiple myeloma: morphology and immunohistochemistry.
Firsova MV; Mendeleeva LP; Kovrigina AM; Solovev MV; Savchenko VG
BMC Cancer; 2020 Apr; 20(1):346. PubMed ID: 32321465
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of WT1 and VEGF Expression with Angiogenesis in Bone Marrow Biopsies of Multiple Myeloma Patients].
Li GJ; Ding H; Yang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):733-6. PubMed ID: 26117027
[TBL] [Abstract][Full Text] [Related]
7. Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
Saatci C; Caglayan AO; Kocyigit I; Akalin H; Kaynar LG; Altuntas F; Eser B; Demir M; Cetin M; Ozkul Y
Hematology; 2010 Feb; 15(1):39-42. PubMed ID: 20132661
[TBL] [Abstract][Full Text] [Related]
8. Frequent hypermethylation of a CTCF binding site influences Wilms tumor 1 expression in Wilms tumors.
Zitzmann F; Mayr D; Berger M; Stehr M; von Schweinitz D; Kappler R; Hubertus J
Oncol Rep; 2014 Apr; 31(4):1871-6. PubMed ID: 24534946
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.
Sakai K; Shimodaira S; Maejima S; Udagawa N; Sano K; Higuchi Y; Koya T; Ochiai T; Koide M; Uehara S; Nakamura M; Sugiyama H; Yonemitsu Y; Okamoto M; Hongo K
J Neurosurg; 2015 Oct; 123(4):989-97. PubMed ID: 26252465
[TBL] [Abstract][Full Text] [Related]
10. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
Oka Y; Tsuboi A; Taguchi T; Osaki T; Kyo T; Nakajima H; Elisseeva OA; Oji Y; Kawakami M; Ikegame K; Hosen N; Yoshihara S; Wu F; Fujiki F; Murakami M; Masuda T; Nishida S; Shirakata T; Nakatsuka S; Sasaki A; Udaka K; Dohy H; Aozasa K; Noguchi S; Kawase I; Sugiyama H
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13885-90. PubMed ID: 15365188
[TBL] [Abstract][Full Text] [Related]
11. Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes.
Azuma T; Otsuki T; Kuzushima K; Froelich CJ; Fujita S; Yasukawa M
Clin Cancer Res; 2004 Nov; 10(21):7402-12. PubMed ID: 15534117
[TBL] [Abstract][Full Text] [Related]
12. Examination of expression of WT1 gene product and CD44 adhesive molecule in nephroblastoma histologic types.
Taran K; Kobos J; Sporny S
Pol J Pathol; 2008; 59(3):177-82. PubMed ID: 19097357
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
15. A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.
Kim MK; Mason JM; Li CM; Berkofsky-Fessler W; Jiang L; Choubey D; Grundy PE; Tycko B; Licht JD
Neoplasia; 2008 Jan; 10(1):69-78. PubMed ID: 18231640
[TBL] [Abstract][Full Text] [Related]
16. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
17. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas.
Ueda T; Oji Y; Naka N; Nakano Y; Takahashi E; Koga S; Asada M; Ikeba A; Nakatsuka S; Abeno S; Hosen N; Tomita Y; Aozasa K; Tamai N; Myoui A; Yoshikawa H; Sugiyama H
Cancer Sci; 2003 Mar; 94(3):271-6. PubMed ID: 12824921
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
